Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab

Kidney Int Rep. 2022 Aug 29;7(10):2317-2318. doi: 10.1016/j.ekir.2022.08.020. eCollection 2022 Oct.

Authors

Takashi Tani^{1

2}, Kenta Sugino^{1

2}, Kazumasa Hashimoto^{1

2}, Akiko Mii¹, Tetsuya Kashiwagi¹, Akira Shimizu³, Yukinao Sakai¹, Masato Iwabu¹

Affiliations

¹ Department of Endocrinology, Metabolism and Nephrology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
² Department of Internal Medicine, Tokyo Rinkai Hospital, Tokyo, Japan.
³ Department of Analytic Human Pathology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

No abstract available